Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT)

Selective Laser Trabeculoplasty (SLT): Efficacy and Safety Outcomes of Optometrist (OD) Performed SLT

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04036214

Acronym

SLT

Enrollment

Registered

2019-07-29

Start date

2019-08-21

Completion date

2022-08-30

Last updated

2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Hypertension, Primary Open-Angle Glaucoma, Unspecified Eye

Brief summary

To measure the efficacy and safety outcomes of SLT performed by optometrists.

Detailed description

Participants will undergo a pre-procedure examination in order to record baseline findings and to determine if they meet the inclusion criteria in order to undergo the procedure. Participants will undergo the SLT procedure and will be examined at 1 hour, 1 week and 6 weeks. Follow up examinations will evaluate eye pressure reduction and post-procedure complications. The rate complication post-procedure are typically low.

Interventions

DEVICESelective Laser Trabeculoplasty

Selective Laser Trabeculoplasty Laser

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Ability to provide written informed consent; 2. At least 18 years of age, male or female, of Native American or Alaskan Native descent; 3. Diagnosed with primary open angle glaucoma or ocular hypertension; 4. Documented intraocular pressure greater than or equal to 23 mmHg; 5. No prior glaucoma treatment unless treated with one topical drop.

Exclusion criteria

1. History of trauma or ocular surgery within the last 6 months; 2. History of corneal dystrophy; 3. Current use of topical or systemic steroids; 4. Advanced or severe glaucomatous findings based on comprehensive examination; 5. Diagnosed with other types of glaucoma such as pseudoexfoliation syndrome, pigmentary glaucoma, normal tension glaucoma, and other additional glaucoma subtypes.

Design outcomes

Primary

Measure	Time frame	Description
Intraocular Pressure via Goldmann tonometry	6 weeks	Pre and Post Procedure Intraocular Pressure will be measured using a Goldmann tonometer and will be measured in millimeters of Mercury (mmHg). Percent change in intraocular pressure will be determined.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026